Marcum Wealth’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $483K | Sell |
971
-58
| -6% | -$28.9K | 0.04% | 197 |
|
|
2024
Q4 | $535K | Sell |
1,029
-79
| -7% | -$41.1K | 0.05% | 185 |
|
|
2024
Q3 | $685K | Sell |
1,108
-60
| -5% | -$37.1K | 0.06% | 151 |
|
|
2024
Q2 | $646K | Buy |
1,168
+6
| +0.5% | +$3.32K | 0.06% | 154 |
|
|
2024
Q1 | $675K | Sell |
1,162
-46
| -4% | -$26.7K | 0.07% | 145 |
|
|
2023
Q4 | $641K | Sell |
1,208
-65
| -5% | -$34.5K | 0.07% | 143 |
|
|
2023
Q3 | $644K | Buy |
1,273
+72
| +6% | +$36.4K | 0.08% | 139 |
|
|
2023
Q2 | $627K | Sell |
1,201
-125
| -9% | -$65.2K | 0.07% | 138 |
|
|
2023
Q1 | $764K | Buy |
1,326
+26
| +2% | +$15K | 0.1% | 124 |
|
|
2022
Q4 | $716K | Buy |
1,300
+33
| +3% | +$18.2K | 0.09% | 126 |
|
|
2022
Q3 | $643K | Buy |
1,267
+155
| +14% | +$78.7K | 0.1% | 130 |
|
|
2022
Q2 | $604K | Buy |
1,112
+53
| +5% | +$28.8K | 0.09% | 136 |
|
|
2022
Q1 | $625K | Buy |
1,059
+60
| +6% | +$35.4K | 0.09% | 134 |
|
|
2021
Q4 | $667K | Sell |
999
-33
| -3% | -$22K | 0.09% | 140 |
|
|
2021
Q3 | $590K | Buy |
1,032
+220
| +27% | +$126K | 0.09% | 138 |
|
|
2021
Q2 | $410K | Sell |
812
-374
| -32% | -$189K | 0.07% | 175 |
|
|
2021
Q1 | $541K | Buy |
1,186
+656
| +124% | +$299K | 0.09% | 140 |
|
|
2020
Q4 | $247K | Buy |
+530
| New | +$247K | 0.06% | 116 |
|